---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-138306"
form_type: "8-K"
ticker: "GH"
cik: "0001576280"
company_name: "Guardant Health, Inc."
filed_at: "2023-05-08T23:59:59+00:00"
generated_at: "2026-06-15T13:18:00.764109+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Guardant Health names Ines Dahne-Steuber COO, promotes Darya Chudova to CTO

## Summary
- Ines Dahne-Steuber appointed COO effective May 3, 2023; previously senior exec at Fresenius Medical Care.
- Compensation: $490k base salary, 50% target bonus, ~$2M in RSUs and ~$2M in stock options (four-year vesting).
- Signing bonus of $50k and relocation allowance up to $50k, subject to 12-month clawback.
- Darya Chudova promoted to CTO; led development of Shield blood-based colorectal cancer screening technology.
- Both appointments effective May 2023, aiming to scale global operations and support product launches.

## SEC filing metadata
- accession: 0001193125-23-138306
- form_type: 8-K
- ticker: GH
- cik: 0001576280
- company_name: Guardant Health, Inc.
- filed_at: 2023-05-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1576280/000119312523138306/0001193125-23-138306-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1576280/000119312523138306/d452070d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-138306
- JSON: https://secwatch.observer/filing/0001193125-23-138306.json
- Plain text: https://secwatch.observer/filing/0001193125-23-138306.txt

## Key facts
- Executive change
  Ines Dahne-Steuber was appointed as Chief Operations Officer at Guardant Health, Inc..
  - Action: appointed
  - Role: Chief Operations Officer
  source text: On May 3, 2023, the Board of Directors (the “Board”) of the Guardant Health, Inc. (the “Company”) appointed Ines Dahne-Steuber to serve as the Company’s Chief Operations Officer, effective May 3, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1576280/000119312523138306/0001193125-23-138306-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.